Now I have excellent source material. Let me compile the comprehensive answer.
Treatment of Sexual Dysfunction with Blunted Affect, Anhedonia & Poor Memory
The symptom cluster you've listed - sexual dysfunction + blunted affect + anhedonia + poor memory + inability to erect + inability to feel sexual arousal + loss of libido - is a classic picture of one of two main conditions (often overlapping):
- Antidepressant-induced sexual dysfunction (especially SSRI/SNRI-related, including Post-SSRI Sexual Dysfunction / PSSD)
- Hypogonadism / testosterone deficiency
Both must be assessed simultaneously. Here is the full treatment framework from the evidence base:
Step 1: Rule Out and Treat Underlying Causes First
Before prescribing antidotes, identify the root cause. The Maudsley Prescribing Guidelines emphasize this is mandatory:
| Possible Cause | Assessment |
|---|
| SSRI/SNRI/antipsychotic use | Compare sexual function before vs. after starting the drug |
| Hypogonadism | Morning serum testosterone (check if <275 ng/dL / <9.5 nmol/L) |
| Hyperprolactinemia | Prolactin level (dopamine blockers, antipsychotics raise prolactin) |
| Diabetes / Vascular | Fasting glucose, HbA1c, lipid profile |
| Cardiovascular disease | BP, BMI, cardiovascular risk assessment |
| Other drugs | Beta-blockers, thiazides, spironolactone, antiandrogens, opiates |
| Depression itself | Untreated depression causes anhedonia, loss of libido, and blunted affect independent of any drug |
Step 2: Optimize the Primary Treatment
If on an SSRI/SNRI:
Switch to a lower-risk antidepressant. These have the best evidence for a favorable sexual adverse effect profile:
| Drug | Sexual Risk Profile | Notes |
|---|
| Agomelatine | Lowest risk | Best evidence for sparing sexual function |
| Bupropion | Low risk | Dopamine/noradrenaline reuptake inhibitor - can actually improve sexual function |
| Vortioxetine | Low risk | Also improves cognitive symptoms (memory, concentration) |
| Mirtazapine | Low risk | 5-HT2 antagonist; also helpful for anhedonia |
| Moclobemide | Low risk | Reversible MAOI |
- The Maudsley Prescribing Guidelines in Psychiatry, 15ed, p.453
- Kaplan & Sadock's Comprehensive Textbook of Psychiatry
Step 3: Pharmacological "Antidote" Treatments
These can be added when switching is not possible or when dysfunction persists:
A. For Erectile Dysfunction (PDE5 Inhibitors)
First-line for erectile dysfunction regardless of cause:
| Drug | Dose | Duration of Action |
|---|
| Sildenafil | Start 50mg, up to 100mg (taken 20-60 min before sex) | 4-6 hrs - best evidence for antidepressant-induced ED |
| Tadalafil | 10-20mg on demand; or 5mg daily (best for frequent use) | Up to 36 hrs |
| Vardenafil | 5-20mg | 4-6 hrs |
- Daily tadalafil 5mg (start 2.5mg) is preferred if intercourse expected >2x/week
- Effective in ~60% of men; slightly lower response in diabetes, post-prostatectomy, spinal cord injury
- Goldman-Cecil Medicine, p.2543
B. For Low Libido, Anhedonia, Blunted Affect (Dopaminergic Agents)
These symptoms respond to dopaminergic enhancement:
| Drug | Mechanism | Use |
|---|
| Bupropion 150-300mg/day | NE + dopamine reuptake inhibitor | SSRI-induced loss of desire, arousal, anorgasmia; also improves anhedonia and cognition |
| Amantadine | Dopamine agonist | Prolactin-induced loss of desire and arousal |
| Bromocriptine | Dopamine agonist | Hyperprolactinemia-induced loss of desire/arousal |
| Aripiprazole 5-10mg | Partial D2 agonist | Normalizes prolactin, improves sexual function; added to antipsychotics |
- Maudsley Prescribing Guidelines, Table 1.46, p.223
C. For Arousal Problems / Anorgasmia (Cholinergic/Serotonin Modulation)
| Drug | Mechanism | Use |
|---|
| Bethanechol | Cholinergic agonist | Anticholinergic-induced arousal problems (from TCAs, antipsychotics) |
| Cyproheptadine 4-16mg | 5-HT2 antagonist | SSRI-induced anorgasmia/arousal dysfunction - but causes sedation |
| Buspirone | 5-HT1A partial agonist | Antidepressant-induced sexual dysfunction |
| Yohimbine | α2-adrenoceptor antagonist | SSRI-induced ED, decreased libido, anorgasmia |
Step 4: Testosterone Replacement (If Deficient)
If morning testosterone is <275 ng/dL (<9.5 nmol/L) with symptoms of deficiency:
| Formulation | Dose |
|---|
| Testosterone gel (topical) | 40-50 mg applied daily |
| Testosterone enanthate/cypionate (IM) | 100-200 mg IM every 2 weeks |
- Testosterone replacement improves libido, erectile function, energy, mood, and lean muscle mass in confirmed hypogonadal men
- In men with ED + testosterone deficiency considering PDE5 inhibitors, testosterone should be corrected first - it enhances PDE5 inhibitor response
- Washington Manual of Medical Therapeutics; Goldman-Cecil Medicine, Harrison's 22E
Step 5: Post-SSRI Sexual Dysfunction (PSSD)
If symptoms persist after stopping the SSRI/SNRI, this is PSSD - a recognized syndrome characterized by:
- Decreased libido, genital numbness, pleasureless orgasm, ED, delayed ejaculation
- May persist months to years after stopping the drug
Management of PSSD (evidence limited, no single ideal approach):
- PDE5 inhibitors (sildenafil, tadalafil) for erectile component
- Bupropion - useful for desire/arousal
- Buspirone
- Pine bark extract (limited data)
- Flibanserin - FDA-approved for hypoactive sexual desire disorder in premenopausal women; no data yet for PSSD specifically
- Psychosexual therapy / sex therapy alongside pharmacotherapy
- Maudsley Prescribing Guidelines, p.453
For Blunted Affect, Anhedonia & Poor Memory Specifically
These cognitive-affective symptoms suggest either:
- Residual depressive symptoms - optimize antidepressant (vortioxetine has pro-cognitive effects; bupropion reduces anhedonia via dopamine)
- SSRI-induced emotional blunting - dose reduction or switch to agomelatine/bupropion/vortioxetine
- Testosterone deficiency - testosterone replacement improves mood, memory, and motivation
Vortioxetine is particularly worth highlighting here because it uniquely addresses both sexual dysfunction (low risk) and cognitive symptoms (memory, concentration, processing speed) simultaneously.
Summary Decision Tree
Sexual dysfunction + anhedonia + poor memory + blunted affect
│
├── On SSRI/SNRI/antipsychotic?
│ YES → Dose reduction / switch to bupropion, agomelatine, or vortioxetine
│ + Add sildenafil/tadalafil for ED
│ + Add bupropion for desire/arousal if not already using
│
├── Testosterone low (<275 ng/dL)?
│ YES → Testosterone replacement (gel or IM)
│ + PDE5 inhibitor for ED if needed
│
├── Prolactin high?
│ YES → Switch antipsychotic / add aripiprazole 5-10mg
│ OR bromocriptine / amantadine
│
└── All normal, no drug cause?
→ Psychosexual therapy + treat any underlying depression
+ PDE5 inhibitor for erectile dysfunction
+ Testosterone if borderline low
Note: Always exclude cardiovascular disease before prescribing PDE5 inhibitors. They are contraindicated with nitrates. Sexual activity itself is a cardiovascular stress test - patient must be cleared for moderate exercise.